Personal information

Activities

Employment (1)

University of Southampton Faculty of Medicine: SouthamptonSouthampton, GB

Employment
Source: Self-asserted source
Salim Khakoo

Education and qualifications (3)

university of London: London, GB

1997-06-01 to present | MD
Qualification
Source: Self-asserted source
Salim Khakoo

University of London: London, GB

1988-06-01 to present | MBBS
Qualification
Source: Self-asserted source
Salim Khakoo

Univeristy of London: London, GB

1986-06-01 to present | BSc (experimental pathology)
Qualification
Source: Self-asserted source
Salim Khakoo

Funding (14)

CRUK Accelerator award

2019-10 to 2024-09 | Grant
Cancer Research UK (Southampton, Hampshire, GB)
Part of GRANT_NUMBER:

HUNTER consortium

Source: Self-asserted source
Salim Khakoo

Developing a predictive in silico toolkit for modeling NK cell responses against RNA virus infections

2019-10 to 2024-09 | Award
National Institutes of Health (Md., Md., US)
Source: Self-asserted source
Salim Khakoo

Targeting natural killer cell receptors for immunotherapeutic benefit

2019-03-31 to 2023-03-30 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/S009388/1
Source: Self-asserted source
Salim Khakoo via DimensionsWizard

University of Southampton – Confidence in Concept 2017

2018-03-01 to 2021-01-31 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MC_PC_17177
Source: Self-asserted source
Salim Khakoo via DimensionsWizard

Future Worlds Medicine: an Innovative Approach to Industrial Collaboration

2017-03-01 to 2019-03-31 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MC_PC_16085
Source: Self-asserted source
Salim Khakoo via DimensionsWizard

University of Southampton – Confidence in Concept

2017-03-01 to 2019-02-28 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MC_PC_16059
Source: Self-asserted source
Salim Khakoo via DimensionsWizard

The immunotherapeutic potential of MHC class I-restricted peptide activation of human natural killer cells

2015-11-01 to 2018-10-31 | Grant
Cancer Research UK (London, GB)
GRANT_NUMBER:

CRUK-A19917

Source: Self-asserted source
Salim Khakoo via DimensionsWizard

Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy

2015-08-31 to 2019-04-29 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/M019829/1
Source: Self-asserted source
Salim Khakoo via DimensionsWizard

Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection

2013-09-15 to 2019-09-14 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/K01532X/1
Source: Self-asserted source
Salim Khakoo via DimensionsWizard

KIR in adaptive immunity: in vivo relevance for human disease

2013-01-02 to 2016-01-01 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: MR/J007439/1
Source: Self-asserted source
Salim Khakoo via DimensionsWizard

Peptide antagonism and NK cell activation: mechanism and relevance

2012-01-09 to 2015-01-08 | Grant
Medical Research Council (London, GB)
GRANT_NUMBER: G1001738
Source: Self-asserted source
Salim Khakoo via DimensionsWizard

Inhibitory natural killer cell receptors: role and mechanism of action in hepatitis C virus infection.

2010-11-01 to 2011-10-31 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

076991/B/05/A

Source: Self-asserted source
Salim Khakoo via DimensionsWizard

Inhibitory natural killer cell receptors: role and mechanism of action in hepatitis C virus infection.

2005-11-01 to 2010-10-31 | Grant
Wellcome Trust (London, GB)
GRANT_NUMBER:

076991/Z/05/Z

Source: Self-asserted source
Salim Khakoo via DimensionsWizard

HCV Replication and Immunity

2000-08-15 to 2011-06-30 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: U19AI048231
Source: Self-asserted source
Salim Khakoo via DimensionsWizard

Peer review (1 review for 1 publication/grant)

Review activity for Cancer immunology and immunotherapy. (1)